1
|
Sharma A, Kaur I, Dheer D, Nagpal M, Kumar P, Venkatesh DN, Puri V, Singh I. A propitious role of marine sourced polysaccharides: Drug delivery and biomedical applications. Carbohydr Polym 2023; 308:120448. [PMID: 36813329 DOI: 10.1016/j.carbpol.2022.120448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2022] [Revised: 11/06/2022] [Accepted: 12/06/2022] [Indexed: 12/14/2022]
Abstract
Numerous compounds, with extensive applications in biomedical and biotechnological fields, are present in the oceans, which serve as a prime renewable source of natural substances, further promoting the development of novel medical systems and devices. Polysaccharides are present in the marine ecosystem in abundance, promoting minimal extraction costs, in addition to their solubility in extraction media, and an aqueous solvent, along with their interactions with biological compounds. Certain algae-derived polysaccharides include fucoidan, alginate, and carrageenan, while animal-derived polysaccharides comprise hyaluronan, chitosan and many others. Furthermore, these compounds can be modified to facilitate their processing into multiple shapes and sizes, as well as exhibit response dependence to external conditions like temperature and pH. All these properties have promoted the use of these biomaterials as raw materials for the development of drug delivery carrier systems (hydrogels, particles, capsules). The present review enlightens marine polysaccharides providing its sources, structures, biological properties, and its biomedical applications. In addition to this, their role as nanomaterials is also portrayed by the authors, along with the methods employed to develop them and associated biological and physicochemical properties designed to develop suitable drug delivery systems.
Collapse
Affiliation(s)
- Ameya Sharma
- Chitkara School of Pharmacy, Chitkara University, Himachal Pradesh, India
| | - Ishnoor Kaur
- Chitkara College of Pharmacy, Chitkara University, Punjab, India; University of Glasgow, College of Medical, Veterinary and Life Sciences, Glasgow, United Kingdom, G12 8QQ
| | - Divya Dheer
- Chitkara School of Pharmacy, Chitkara University, Himachal Pradesh, India
| | - Manju Nagpal
- Chitkara College of Pharmacy, Chitkara University, Punjab, India
| | - Pradeep Kumar
- Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - D Nagasamy Venkatesh
- JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Tamil Nadu, India
| | - Vivek Puri
- Chitkara School of Pharmacy, Chitkara University, Himachal Pradesh, India.
| | - Inderbir Singh
- Chitkara College of Pharmacy, Chitkara University, Punjab, India.
| |
Collapse
|
2
|
Shejul PP, Raheja RK, Doshi GM. An Update on Potential Antidepressants Derived from Marine Natural Products. Cent Nerv Syst Agents Med Chem 2023; 23:71-85. [PMID: 37622698 DOI: 10.2174/1871524923666230825105035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2023] [Revised: 07/11/2023] [Accepted: 07/31/2023] [Indexed: 08/26/2023]
Abstract
INTRODUCTION Depression is one of the most frequently occurring psychiatric disorders worldwide, affecting 121 million worldwide. World Health Organization (WHO) estimates that it is the leading cause of disability and the fourth leading contributor to the "global burden of diseases". OBJECTIVE Investigating and developing a drug with a novel benefit-risk profile is critical. Marine sources have been explored for their benefits as an alternative therapy for depression treatment. Numerous studies have shown that natural compounds containing peptides, alkaloids, polyphenols, diterpenes, glycosides, vitamins, and minerals from marine sources can potentially treat a wide range of disorders, including depression. Such phytoconstituents are known to reduce oxidative stress and neuroinflammation, regulate the synthesis or function of neurotransmitters such as glutamate and acetylcholinesterase, and aid in enhancing serotonin levels and nerve development. METHODS In this review study, a literature search was conducted using terms often used, including animal models of depression and their precise phases, marine sources, algae, sponges, and indole alkaloids. Additionally, databases were examined, including Scopus, Wiley, Elsevier, Google Scholar, and Web of Science. The Snowball technique was used to identify several articles about depression but correlated to marine sources in addition to database searches. RESULTS Current antidepressant medications have several negative side effects on the human body, including dry mouth, cardiovascular interference, gastrointestinal symptoms, genitourinary symptoms, hepatotoxicity, convulsions, and obesity. As a result, researchers can identify a wide range of potential targets for medications derived from marine sources. A combination of marinederived drugs and available treatments can be estimated to minimize the negative effects. So that these resources can be used as efficiently as possible, and various marine-derived substances can be studied for therapeutic efficacy. CONCLUSION This review focuses on the preclinical and clinical findings of marine-derived compounds with antidepressant properties that alter behavioural parameters and biochemical abnormalities, as well as their mechanism of action and in-vivo potential.
Collapse
Affiliation(s)
- Priya P Shejul
- Department of Pharmacology, Toxicology and Therapeutics SVKM's Dr. Bhanuben Nanavati College of Pharmacy, V.M. Road, Vile Parle (W), Mumbai, 400056, India
| | - Radhika K Raheja
- Department of Pharmaceutical Chemistry and Quality Assurance, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, V.M.Road, Vile Parle (W), Mumbai, 400056, India
| | - Gaurav M Doshi
- Department of Pharmacology, Toxicology and Therapeutics SVKM's Dr. Bhanuben Nanavati College of Pharmacy, V.M. Road, Vile Parle (W), Mumbai, 400056, India
| |
Collapse
|
3
|
Balu SK, Andra S, Jeevanandam J, S MV, V S. Emerging marine derived nanohydroxyapatite and their composites for implant and biomedical applications. J Mech Behav Biomed Mater 2021; 119:104523. [PMID: 33940538 DOI: 10.1016/j.jmbbm.2021.104523] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2021] [Revised: 03/29/2021] [Accepted: 04/05/2021] [Indexed: 01/30/2023]
Abstract
Implant materials must mimic natural human bones with biocompatibility, osteoconductivity and mechanical stability to successfully replace damaged or disease-affected bones. Synthetic hydroxyapatite was incorporated with bioglass to mimic natural bones for replacing conventional implant materials which has led to certain toxicity issues. Hence, hydroxyapatite (HAp) are recently gaining applicational importance as they are resembling the structure and function of natural bones. Further, nanosized HAp is under extensive research to utilize them as a potential replacement for traditional implants with several exclusive properties. However, chemical synthesis of nano-HAp exhibited toxicity towards normal and healthy cells. Recently, biogenic Hap synthesis from marine and animal sources are introduced as a next generation implant materials, due to their mineral ion and significant porous architecture mediated biocompatibility and bone bonding ability, compared to synthetic HAp. Thus, the purpose of the paper is to give a bird's eye view into the conventional approaches for fabricating nano-HAp, its limitations and the significance of using marine organisms and marine food wastes as a precursor for biogenic nano-Hap production. Moreover, in vivo and in vitro analyses of marine source derived nano-HAp and their potential biomedical applications were also discussed.
Collapse
Affiliation(s)
- Satheesh Kumar Balu
- Department of Ceramic Technology, Anna University, Chennai, Tamil Nadu, 600025, India
| | - Swetha Andra
- Center for Nanoscience and Technology, Chennai Institute of Technology, Chennai, Tamil Nadu, 600069, India
| | - Jaison Jeevanandam
- CQM-Centro de Quimica da Madeira, MMRG, Universidade da Madeira, Campus da Penteada, 9020-105, Funchal, Portugal
| | - Manisha Vidyavathy S
- Department of Ceramic Technology, Anna University, Chennai, Tamil Nadu, 600025, India.
| | - Sampath V
- Department of Metallurgical and Materials Engineering, Indian Institute of Technology Madras, Chennai, Tamil Nadu, 600036, India
| |
Collapse
|
4
|
Abhari K, Mousavi Khaneghah A. Alternative extraction techniques to obtain, isolate and purify proteins and bioactive from aquaculture and by-products. Adv Food Nutr Res 2019; 92:35-52. [PMID: 32402446 DOI: 10.1016/bs.afnr.2019.12.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Oceans cover more than 70% of the earth's surface and provide a great ecosystem for habitat of a large divers of marine species. The marine species are rich sources of bioactive compound that can be applied in medicine, pharmacology and food industry. Besides the marine species, fish processing industry also produces substantial volumes of by-products that can be used for a variety of purposes. Thus, it is important to find approaches to access to these valuable compounds. Nowadays, more factors have been considered in selecting an appropriate method for extraction of bioactive compounds such as consume less time and solvent, to be fast and ecofriendly. Concerns regarding entering the pollutions to the environment resulted to invest on the methods practicable with less chemical solvents and even green ones, however, implementation of stricter regulations and policies is required to encourage researchers to set up the procedures with reduced toxic agents to guarantee the environmental safety. In the current chapter the most common marine derived compounds and innovative methods for their extraction will be discussed.
Collapse
Affiliation(s)
- Khadijeh Abhari
- Department of Food Science and Technology, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Amin Mousavi Khaneghah
- Department of Food Science, Faculty of Food Engineering, State University of Campinas (UNICAMP), São Paulo, Brazil.
| |
Collapse
|
5
|
Cepas V, López Y, Gabasa Y, Martins CB, Ferreira JD, Correia MJ, Santos LMA, Oliveira F, Ramos V, Reis M, Castelo-Branco R, Morais J, Vasconcelos V, Probert I, Guilloud E, Mehiri M, Soto SM. Inhibition of Bacterial and Fungal Biofilm Formation by 675 Extracts from Microalgae and Cyanobacteria. Antibiotics (Basel) 2019; 8:antibiotics8020077. [PMID: 31212792 PMCID: PMC6628188 DOI: 10.3390/antibiotics8020077] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2019] [Revised: 06/03/2019] [Accepted: 06/05/2019] [Indexed: 11/17/2022] Open
Abstract
Bacterial biofilms are complex biological systems that are difficult to eradicate at a medical, industrial, or environmental level. Biofilms confer bacteria protection against external factors and antimicrobial treatments. Taking into account that about 80% of human infections are caused by bacterial biofilms, the eradication of these structures is a great priority. Biofilms are resistant to old-generation antibiotics, which has led to the search for new antimicrobials from different sources, including deep oceans/seas. In this study, 675 extracts obtained from 225 cyanobacteria and microalgae species (11 phyla and 6 samples belonging to unknown group) were obtained from different culture collections: The Blue Biotechnology and Ecotoxicology Culture Collection (LEGE-CC), the Coimbra Collection of Algae (ACOI) from Portugal, and the Roscoff Culture Collection (RCC) from France. The largest number of samples was made up of the microalgae phylum Chlorophyta (270) followed by Cyanobacteria (261). To obtain a large range of new bioactive compounds, a method involving three consecutive extractions (hexane, ethyl acetate, and methanol) was used. The antibiofilm activity of extracts was determined against seven different bacterial species and two Candida strains in terms of minimal biofilm inhibitory concentration (MBIC). The highest biofilm inhibition rates (%) were achieved against Candida albicans and Enterobacter cloacae. Charophyta, Chlorophyta, and Cyanobacteria were the most effective against all microorganisms. In particular, extracts of Cercozoa phylum presented the lowest MBIC50 and MBIC90 values for all the strains except C. albicans.
Collapse
Affiliation(s)
- Virginio Cepas
- ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
| | - Yuly López
- ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
| | - Yaiza Gabasa
- ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
| | - Clara B Martins
- Coimbra Collection of Algae (ACOI), Department of Life Sciences, University of Coimbra, 3000-456 Coimbra, Portugal.
| | - Joana D Ferreira
- Coimbra Collection of Algae (ACOI), Department of Life Sciences, University of Coimbra, 3000-456 Coimbra, Portugal.
| | - Maria J Correia
- Coimbra Collection of Algae (ACOI), Department of Life Sciences, University of Coimbra, 3000-456 Coimbra, Portugal.
| | - Lília M A Santos
- Coimbra Collection of Algae (ACOI), Department of Life Sciences, University of Coimbra, 3000-456 Coimbra, Portugal.
| | - Flávio Oliveira
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), 4450-208 Porto, Portugal.
| | - Vitor Ramos
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), 4450-208 Porto, Portugal.
| | - Mariana Reis
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), 4450-208 Porto, Portugal.
| | - Raquel Castelo-Branco
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), 4450-208 Porto, Portugal.
| | - João Morais
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), 4450-208 Porto, Portugal.
| | - Vitor Vasconcelos
- Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), 4450-208 Porto, Portugal.
- Faculty of Sciences, University of Porto, 4450-208 Porto, Portugal.
| | - Ian Probert
- Roscoff Culture Collection, Sorbonne University/CNRS, Roscoff Biological Station, 29680 Roscoff, France.
| | - Emilie Guilloud
- Roscoff Culture Collection, Sorbonne University/CNRS, Roscoff Biological Station, 29680 Roscoff, France.
| | - Mohamed Mehiri
- Marine Natural Products Team, Nice Institute of Chemistry, UMR 7272 University Nice Côte d'Azur/CNRS, 60103 Nice, France.
| | - Sara M Soto
- ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
| |
Collapse
|
6
|
Abstract
DHA is a key nutritional n-3 PUFA and needs to be supplied by the human diet. DHA is found in significant amounts in the retinal and neuronal cell membranes due to its high fluidity. Indeed, DHA is selectively concentrated in the synaptic and retinal membranes. DHA is deemed to display anti-inflammatory properties and to reduce the risk of CVD. Consumption of larger amounts of DHA appears to reduce the risk of depression, bipolar disorder, schizophrenia and mood disorders. Conversely, it has been shown that loss of DHA from the nerve cell membrane leads to dysfunction of the central nervous system in the form of anxiety, irritability, susceptibility to stress, dyslexia, impaired memory and cognitive functions, and extended reaction times. DHA plays an important role in ensuring a healthy ageing, by thwarting macular degeneration, Alzheimer's disease, and other brain disorders at the same time as enhancing memory and strengthening neuroprotection in general. A reduced level of DHA is associated with cognitive decline during ageing. Different mechanisms for this fundamental DHA role have been put forward. Namely, neuroprotectin D1, a DHA derivative, may support brain cell survival and repair through neurotrophic, anti-apoptotic, and anti-inflammatory signalling. Many of the effects of DHA on the neurological system may be related to signalling connections, thus leading to the study of the related signalolipidomics. Therefore, the present review will focus on the influence of DHA deficiency upon ageing, with specific emphasis upon neurological disorders related to cognitive function and mental health.
Collapse
|